Delivery Order SPE2DB24D2101-SPE2DB25FKJDG
Award Date
4/1/25
Potential Completion Date
4/2/25
Potential Value
$2.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,956.88, is a delivery order for the supply of RUXIENCE 500 MG/50 ML VIAL 50ML, a pharmaceutical product. The contract has an ultimate completion date of March 14, 2025 and is a firm fixed-price contract. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,441.36, is for the supply of RUXIENCE 500 MG/50 ML VIAL 50ML, a medical product, to support federal healthcare programs. The contract has an ultimate completion date of January 29, 2025. This award is part of AmerisourceBergen's larger Indefinite...
This federal contract award, valued at $2,446.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RUXIENCE 500 MG/50 ML VIAL 50ML, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of January 21, 2025 and is a Firm Fixed Price Delivery Order, with no set-aside designation indicated....
This is a $53,734.79 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of RUXIENCE 500 MG/50 ML VIAL 50ML. The contract has an ultimate completion date of September 10, 2024 and is not set aside for any specific business type. AmerisourceBergen has been awarded numerous Indefinite Delivery Contracts (IDCs) by the DLA and other federal agencies, valued up to $999,999,999, to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,728.70 firm fixed price delivery order is for the supply of RUXIENCE 500 MG/50 ML VIAL 50ML, a pharmaceutical product. The contract has an ultimate completion date of December 28, 2023 and was awarded on December 27, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order to supply RUXIENCE 500 MG/50 ML VIAL 50ML, a pharmaceutical product, with a potential value of $3,782.96 and a completion date of February 27, 2024. This award is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, to provide a comprehensive range of...
This federal contract award, valued at $25,827.78, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the drug RUXIENCE 500 MG/50 ML VIAL 50ML. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,726.50 contract is for the supply of RUXIENCE 500 MG/50 ML VIAL 50ML, a pharmaceutical product, with a period of performance through March 2025. The award is not associated with a set-aside program. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,789.36, is for the delivery of Ruxience 500 mg/50 ml vial, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of February 26, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,692.87 Firm Fixed Price Delivery Order contract is for the supply of 4566976401 RUXIENCE 500 MG/50 ML VIAL 50ML, a pharmaceutical product. The contract has a completion date of January 21, 2025 and was awarded on January 17, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...